Cited by 281Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchAsthma and respiratory diseases

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study

Open access
Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., Ricciardi, L.·2001·Clinical & Experimental Allergy

Abstract

Background Specific immunotherapy is the only currently available allergen‐orientated treatment able to modify the natural history of respiratory allergic diseases. Safety and clinical efficacy of this treatment are well documented, but evidence about the ability to reduce new sensitizations is still poor. Objective We report a retrospective study conducted in order to assess the prevention of new sensitizations in monosensitized subjects treated with specific immunotherapy vs. monosensitized patients treated with anti‐allergic drugs. Methods 8396 monosensitized patients with respiratory symptoms were selected according to an open, retrospective design. Group A included 7182 patients submitted to specific immunotherapy (and anti‐allergic drugs when needed) for 4 years and then treated with drugs for at least 3 years. Group B included 1214 patients treated only with drugs for at least 7 years. All patients underwent prick test with a standard panel of allergens and total and specific IgE determination before and after 4 years of treatment and again 3 years later. Results Groups were well balanced. Polysensitized subjects were 23.75% in Group A and 68.03% in Group B after 4 years (P < 0.0001) and 26.95% and 76.77%, respectively, after 7 years (P < 0.0001). Asthmatic subjects were more prone to develop polysensitization in comparison to subjects suffering only from rhinitis (32.14% instead of 27.29% after 4 years, 36.5% instead of 31.33% after 7 years; P < 0.0001). Specific IgE decreased by 24.11% in Group A and increased by 23.87% in Group B (P < 0.0001). Total IgE decreased by 17.53% in Group A and increased by 13.71% in Group B (P < 0.0001). Conclusions Specific immunotherapy was observed retrospectively to reduce new sensitizations in monosensitized subjects suffering from respiratory allergic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2222.2001.01027.x

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Allergen immunotherapy is thought to help halt progression of allergic disease, including prevention of new allergic sensitivities and development of asthma.

    “AIT is also thought to help halt the progression of allergic disease, including prevention of new allergic sensitivities and the development of asthma.1624,1626,1678,1797,1798,1824-1826”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Jacobsen L. The benefit of specific allergy treatment. In: Basomba, A, Sastre, J, eds. Proceedings of the XVI European Congress of Allergology and Clinical Immunology. Bologna. Italy: Monduzzi Editore, 1995: 145±50.
  2. Jacobsen L, Dreborg S, Moeller C et al. Immunotherapy as a preventive treatment. J All Clin Immunol 1996; 97:232(Abstract).
  3. D'Amato G, Burge HA, Hoyer MF. Variazioni antigeniche nei ceppi e nei lotti di Alternaria isolati in Ann Arbor e in Napoli. G Ital Allergol Immunol Clin 1991; 1:133±9.
  4. Des Roches A, Paradis L, Knani J et al. Specific immuno- therapy prevents the onset of new sensitizations in mono- sensitized children. [Abstract]. J Allergy Clin Immunol 1995; 95:309.

Cited by

Sorted by citations

Authors
Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L.
Affiliations
  • University of Messina (IT)
  • ALK-Abelló (Italy) (IT)
Corresponding author
Gangemi, S.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2001-08
Volume
31
Issue
8
Pages
1295-1302
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2085196853
Cited by
281
References
76
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 16 · 2015: 14 · 2014: 17 · 2013: 9 · 2012: 14
FWCI
5.74
Type
journal article
Language
en
Open access
Locations
  • Clinical & Experimental Allergy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
allergen immunotherapy, polysensitization, allergic respiratory diseases, asthma, allergic rhinitis, antiallergic drugs, specific IgE, total IgE, allergen sensitization
MeSH terms
Contraindications, Administration, Inhalation, Administration, Oral, Adult, Allergens, Epitopes, Asthma, Desensitization, Immunologic, Drug Administration Schedule, Female, Follow-Up Studies, Histamine H1 Antagonists, Humans, Hypersensitivity, Delayed, Immunoglobulin E, Italy, Male, Retrospective Studies, Rhinitis, Receptors, Adrenergic, beta-2, Anti-Allergic Agents, Adrenergic beta-2 Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review